Abbas Al Mutair

5.5k total citations · 1 hit paper
153 papers, 2.9k citations indexed

About

Abbas Al Mutair is a scholar working on Infectious Diseases, Clinical Psychology and General Health Professions. According to data from OpenAlex, Abbas Al Mutair has authored 153 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Infectious Diseases, 27 papers in Clinical Psychology and 26 papers in General Health Professions. Recurrent topics in Abbas Al Mutair's work include SARS-CoV-2 and COVID-19 Research (31 papers), COVID-19 Clinical Research Studies (29 papers) and Long-Term Effects of COVID-19 (14 papers). Abbas Al Mutair is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (31 papers), COVID-19 Clinical Research Studies (29 papers) and Long-Term Effects of COVID-19 (14 papers). Abbas Al Mutair collaborates with scholars based in Saudi Arabia, Australia and Myanmar. Abbas Al Mutair's co-authors include Saad Alhumaid, Ali A. Rabaan, Virginia Plummer, Awad Al‐Omari, Kuldeep Dhama, Rosemary Clerehan, Anthony O’Brien, Zainab Al Alawi, Jaffar A. Al‐Tawfiq and Talha Bin Emran and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Abbas Al Mutair

140 papers receiving 2.8k citations

Hit Papers

Global emerging Omicron variant of SARS-CoV-2: Impacts, c... 2022 2026 2023 2024 2022 40 80 120

Peers

Abbas Al Mutair
Abbas Al Mutair
Citations per year, relative to Abbas Al Mutair Abbas Al Mutair (= 1×) peers Andrea Cortegiani

Countries citing papers authored by Abbas Al Mutair

Since Specialization
Citations

This map shows the geographic impact of Abbas Al Mutair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abbas Al Mutair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abbas Al Mutair more than expected).

Fields of papers citing papers by Abbas Al Mutair

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abbas Al Mutair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abbas Al Mutair. The network helps show where Abbas Al Mutair may publish in the future.

Co-authorship network of co-authors of Abbas Al Mutair

This figure shows the co-authorship network connecting the top 25 collaborators of Abbas Al Mutair. A scholar is included among the top collaborators of Abbas Al Mutair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abbas Al Mutair. Abbas Al Mutair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mutair, Abbas Al, et al.. (2025). A meta analysis of efficacy and safety of nefopam for laparoscopic cholecystectomy pain management. Journal of Taibah University Medical Sciences. 20(2). 191–200.
3.
Mutair, Abbas Al, et al.. (2024). Comparison of anterior and posterior approaches for functional improvement in cervical myelopathy: A systematic review and meta-analysis of 33,025 patients. North American Spine Society Journal (NASSJ). 22. 100567–100567. 1 indexed citations
6.
Tallei, Trina Ekawati, Fatimawali Fatimawali, İsmail Çeli̇k, et al.. (2022). 4’-fluorouridine and its derivatives as potential COVID-19 oral drugs: a review. F1000Research. 11. 410–410. 2 indexed citations
7.
Rabaan, Ali A., Saad Alhumaid, Hawra Albayat, et al.. (2022). Promising Antimycobacterial Activities of Flavonoids against Mycobacterium sp. Drug Targets: A Comprehensive Review. Molecules. 27(16). 5335–5335. 16 indexed citations
8.
Rabaan, Ali A., Muhammed A. Bakhrebah, Majed S. Nassar, et al.. (2022). Suspected Adenovirus Causing an Emerging HEPATITIS among Children below 10 Years: A Review. Pathogens. 11(7). 712–712. 11 indexed citations
9.
Rabaan, Ali A., Saad Alhumaid, Abbas Al Mutair, et al.. (2022). Application of Artificial Intelligence in Combating High Antimicrobial Resistance Rates. Antibiotics. 11(6). 784–784. 70 indexed citations
10.
Hajissa, Khalid, Mohmed Isaqali Karobari, Sonu Acharya, et al.. (2022). The SARS-CoV-2 Antibodies, Their Diagnostic Utility, and Their Potential for Vaccine Development. Vaccines. 10(8). 1346–1346. 5 indexed citations
11.
Choudhary, Om Prakash, Priyanka Choudhary, Hitesh Chopra, et al.. (2022). Reverse zoonosis and its relevance to the monkeypox outbreak 2022. New Microbes and New Infections. 49-50. 101049–101049. 24 indexed citations
12.
Rabaan, Ali A., Muhammed A. Bakhrebah, Mohammed Garout, et al.. (2022). Global Prevalence of Colistin Resistance in Klebsiella pneumoniae from Bloodstream Infection: A Systematic Review and Meta-Analysis. Pathogens. 11(10). 1092–1092. 43 indexed citations
13.
Dinesh, M., Manish Dhawan, Ruchi Tiwari, et al.. (2022). Prophylactic and therapeutic insights into trained immunity: A renewed concept of innate immune memory. Human Vaccines & Immunotherapeutics. 18(1). 2040238–2040238. 20 indexed citations
14.
Rabaan, Ali A., Abbas Al Mutair, Mohammed Aljeldah, et al.. (2022). Genetic Variants and Protective Immunity against SARS-CoV-2. Genes. 13(12). 2355–2355. 3 indexed citations
15.
Hossain, Md. Jamal, Ali A. Rabaan, Abbas Al Mutair, et al.. (2022). Strategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines. Human Vaccines & Immunotherapeutics. 18(1). 2027197–2027197. 9 indexed citations
16.
Rabaan, Ali A., Muhammed A. Bakhrebah, Saad Alhumaid, et al.. (2022). Artificial Intelligence for Clinical Diagnosis and Treatment of Prostate Cancer. Cancers. 14(22). 5595–5595. 27 indexed citations
17.
Naveed, Muhammad, Urooj Ali, Ali A. Rabaan, et al.. (2022). Execution and Design of an Anti HPIV-1 Vaccine with Multiple Epitopes Triggering Innate and Adaptive Immune Responses: An Immunoinformatic Approach. Vaccines. 10(6). 869–869. 23 indexed citations
18.
Koritala, Thoyaja, Vishwanath Pattan, Raghavendra Tirupathi, et al.. (2021). Infection risk with the use of interleukin inhibitors in hospitalized patients with COVID-19: A narrative review. Infezioni in Medicina. 29(4). 495–503. 15 indexed citations
19.
Koritala, Thoyaja, Raghavendra Tirupathi, Ali A. Rabaan, et al.. (2021). A narrative review of emergency use authorization versus full FDA approval and its effect on COVID-19 vaccination hesitancy. Infezioni in Medicina. 29(3). 339–344. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026